Table 2 Antibodies used.

From: Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

Antibody

Dilution

Technique

Source

Catalogue/Product #

β-Amyloid 1–16, (6E10)

1:1,000

1:1,000

1:1,000

WB

IHC

IF

Biolegend

803003

β-Amyloid 17–24 (4G8)

1:500

IF

Biolegend

800708

APP A4 66–81, (22C11)

1:1,000

1:1,000

WB

IHC

Millipore

MAB-348

APP 676–695 (C1/6.1)

1:10,000

WB

Biolegend

802801

BACE1

1:1,000

WB

GeneScript

A00879

GFAP (G-A-5)

1:10,000

1:1,000

WB

IF

Sigma

G 3892

GFAP GA5-Cy3

1:500

IF

Sigma

MAB3402

Iba1

1:1,000

1:500

WB

IF

Wako

019-19741

NQO1

1:1,000

WB

Abcam

ab34173

NQO1 (A180)

1:200

IF

Santa Cruz

sc-32793

GCLM

1:1,000

WB

Dr. Terry Kavanagh

University of Washington

β-Actin (8H10D10)

1:10,000

WB

Cell Signalling Technology

3700

anti-NeuN

1:400

IF

Millipore Bioscience

MAB377

anti-phosphotau AT8

1:1000

IF

Autogen Bioclear

90206

Neurochrom-Cy3

1:500

IF

Millipore Bioscience

ABN2300C3

Anti-Aldh1l1

1:500

IF

Abcam

ab87117

SQSTM1/p62

1:1,000

WB

Abnova

H00008878-B01

NF200 (NE14)

 

WB

EMD Millipore

N5389

NF200 (N52)

1:1000

WB

EMD Millipore

MAB5266

PSD-95

1:1000

WB

Abcam

ab12093

Synapsin-1

1:1000

WB

Synaptic Systems

106 103